Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
P&G (PG) flagship mass-market skincare brand with retinol, niacinamide, and Amino-Peptide Complex across Regenerist and Luminous lines; competing with CeraVe and The Ordinary for skincare-educated consumers.
Olay is Procter & Gamble's flagship mass-market skincare brand — offering anti-aging moisturizers, serums, cleansers, and eye creams formulated with clinically validated ingredients including retinol, niacinamide, vitamin C, and the proprietary Amino-Peptide Complex across multiple product lines (Regenerist, Luminous, Total Effects, Age Defying) that target specific skin concerns from fine lines and uneven tone to dryness and dark spots. Owned by Procter & Gamble (NYSE: PG) and sold in 80+ countries, Olay generates billions in annual skincare revenue as one of P&G's most recognizable beauty brands.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.